| SB 0086 | Mandates insurance coverage for new phases of clinical trials and certain prostate examinations |
| Sponsor: | Dougherty | |||
| LR Number: | 0446S.01I | Fiscal Note: | 0446-01 | |
| Committee: | Small Business, Insurance & Industrial Relations | |||
| Last Action: | 01/14/03 - Second Read and Referred S Small Business, Insurance | Journal page: | S75 | |
| and Industrial Relations Committee | ||||
| Title: | ||||
| Effective Date: | August 28, 2003 | |||
SB 86 - This act requires health insurance companies to provide coverage for routine patient care costs incurred as the result of phase I or II clinical trials undertaken to treat cancer. Currently, Section 376.429, RSMo, requires coverage for phases III or IV only.
This act modifies the mandated prostate examination provision of the law by requiring coverage for bone scans and prostrate antibody imaging for a nonsymptomatic man for whom there was an earlier diagnosis and as a guide for appropriate therapy for patients who have an above normal prostrate specific antigen.
This act changes the procedure in which parental or guardian consent is noted for the organ donation process of minors. Under current law, parental or guardian consent must be noted on the minor's donor card, application for the donor's instruction permit or driver's license, or other document of gift. This act states that the consent can be noted on the permit or license; not the application.
This act is similar to SB 822 (2002) and SB 588 (2001).
STEPHEN WITTE